JN
JNJ
—·NASDAQ
JNJ
TA Patterns
Key Statistics
| Prev. Close | $280.85 | Market Cap | 86B | |
| Open | $282.57 | Shares Out. | 206M | |
| Day's Range | $279.71 – $292.29 | P/E Ratio | 31.00 | |
| 52 Wk Range | $194.48 – $423.28 | EPS | $9.23 | |
| Volume | — | Div. Yield | — | |
| Avg. Volume | 7M | Beta | 1.10 |
JNJ News & Analysis
No news available.
Technical Analysis
Summary — Hourly
2 Sell3 Neutral8 Buy
NeutralMoving Averages4 Sell8 Neutral12 Buy
BuySummary2 Sell5 Neutral4 Buy
NeutralOscillators8 Buy3 Neutral2 Sell
| Indicator | Value | Signal |
|---|---|---|
| MA(5) | 284.28 | Buy |
| MA(10) | 282.57 | Buy |
| MA(20) | 278.85 | Neutral |
| MA(50) | 272.27 | Buy |
| MA(100) | 267.12 | Neutral |
| MA(200) | 260.26 | Sell |
| EMA(5) | 284.86 | Buy |
| EMA(10) | 283.14 | Buy |
| EMA(20) | 279.71 | Neutral |
| EMA(50) | 273.42 | Neutral |
| EMA(100) | 268.27 | Sell |
| EMA(200) | 261.40 | Sell |
Company Profile
JNJ operates in the Healthcare sector. Provides medical products, pharmaceuticals, and healthcare services.
SectorHealthcare
ExchangeNASDAQ
Shares Out.206M
Beta1.10
Peer Comparison
Analyst Ratings & Earnings
Analyst RatingsBuy
Buy30
Hold13
Sell4
Overall ConsensusBuy
Analysts 12-Month Price Target$346.06
Earnings
Aug 15, 2026 · 81d
| Quarter | EPS Est. | Actual | Surprise |
|---|---|---|---|
| Q1 2026 | $6.29 | $6.86 | +9.1% |
| Q4 2025 | $6.01 | $5.72 | -4.8% |
| Q3 2025 | $5.72 | $6.29 | +10.0% |
| Q2 2025 | $5.43 | $6.01 | +10.7% |